Exact Mass: 447.140893
Exact Mass Matches: 447.140893
Found 459 metabolites which its exact mass value is equals to given mass value 447.140893
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Aripiprazole
Aripiprazole is a warning has gone out recently because of this drugs name. The -prazole ending of this drug name makes this drug sound like it is one of the proton pump inhibitors (such as omeprazole, pantoprazole, lansoprazole) which are used in treating peptic ulcer disease. However, aripiprazole and these drugs are in an entirely different class of drugs altogether and confusing the two can lead to some unnecessary side effects. Aripiprazole is the sixth and most recent of the atypical antipsychotic medications to be approved by the Food and Drug Administration (FDA) for the treatment of schizophrenia. It has also recently received FDA approval for the treatment of acute manic and mixed episodes associated with bipolar disorder. Aripiprazole appears to mediate its antipsychotic effects primarily by partial agonism at the Dopamine 2 (D2)receptor. Aripiprazole is an atypical antipsychotic and antidepressant used in the treatment of schizophrenia, bipolar disorder, and clinical depression. OPC is found in chinese cinnamon. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Aripiprazole (OPC-14597), an atypical antipsychotic, is a potent and high-affinity dopamine D2 receptor partial agonist. Aripiprazole is an inverse agonist at 5-HT2B and 5-HT2A receptors and displays partial agonist actions at 5-HT1A, 5-HT2C, D3, and D4 receptors. Aripiprazole can be used for the research of schizophrenia and COVID19[1][2][3][4].
Cyflumetofen
C24H24F3NO4 (447.16573400000004)
D010575 - Pesticides > D056810 - Acaricides D016573 - Agrochemicals
ampiroxicam
C20H21N3O7S (447.11001560000005)
A benzothiazine that is the 1-[(ethoxycarbonyl)oxy]ethyl ether of piroxicam. A prodrug for piroxicam, it is used for the relief of pain and inflammation in musculoskeletal disorders such as rheumatoid arthritis and osteoarthritis. C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
Peonidin 3-rhamnoside
Peonidin 3-rhamnoside is found in pulses. Peonidin 3-rhamnoside is isolated from legumes. Isolated from legumes. Peonidin 3-rhamnoside is found in pulses.
Pigment A aglycone
Pigment A aglycone is a polyphenol compound found in foods of plant origin (PMID: 20428313)
Hydromorphone-3-glucoside
Hydromorphone-3-glucoside is a metabolite of hydromorphone. Hydromorphone, a more common synonym for dihydromorphinone, commonly a hydrochloride (brand names Palladone, Dilaudid, and numerous others) is a very potent centrally acting analgesic drug of the opioid class. It is a derivative of morphine, to be specific, a hydrogenated ketone thereof and, therefore, a semi-synthetic drug. It is, in medical terms, an opioid analgesic and, in legal terms, a narcotic. (Wikipedia)
7-t-Butoxyiminomethyl-camptothecin
Ampiroxicam
C20H21N3O7S (447.11001560000005)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
Amuvatinib
C23H21N5O3S (447.1365036000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
Ccris 6861
C20H21N3O9 (447.12777360000007)
D000970 - Antineoplastic Agents > D000903 - Antibiotics, Antineoplastic > D008937 - Mitomycins
Elvitegravir
C23H23ClFNO5 (447.12487100000004)
Methyl (2S)-2-[[4-[[(2R)-2-amino-3-sulfanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulfanylbutanoate
C22H29N3O3S2 (447.16502440000005)
Gimatecan
Normorphine 3-glucuronide
Petunidin 3-rhamnoside
Petunidin 3-rhamnoside is a member of the class of compounds known as anthocyanidin-3-o-glycosides. Anthocyanidin-3-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C3-position. Petunidin 3-rhamnoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Petunidin 3-rhamnoside can be found in common bean, green bean, and yellow wax bean, which makes petunidin 3-rhamnoside a potential biomarker for the consumption of these food products.
cyanidin 5-O-beta-D-glucoside
C21H19O11- (447.09273240000005)
Cyanidin 5-o-beta-d-glucoside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Cyanidin 5-o-beta-d-glucoside can be found in a number of food items such as broad bean, rambutan, nopal, and garden onion, which makes cyanidin 5-o-beta-d-glucoside a potential biomarker for the consumption of these food products. Cyanidin 5-o-β-d-glucoside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Cyanidin 5-o-β-d-glucoside can be found in a number of food items such as broad bean, rambutan, nopal, and garden onion, which makes cyanidin 5-o-β-d-glucoside a potential biomarker for the consumption of these food products.
Oxaline
An indole alkaloid with a heterotetracyclic skeleton isolated from Penicillium oxalicum and has been shown to exhibit cytotoxic activity. CONFIDENCE Penicillium amphipolaria
Luteolinidin 4-glucuronide
C21H19O11 (447.09273240000005)
Peonidin 3-rhamnoside
N1-[3-(Methylthio)phenyl]-2-{[3-cyano-4,6-dimethyl-5-(2-phenyldiaz-1-enyl)-2-pyridyl]thio}acetamide
O5-{4-[(Dipropylamino)sulfonyl]benzoyl}-1,3-benzodioxole-5-carbohydroximamide
C21H25N3O6S (447.14639900000003)
2-[[4-(2,4-dihydroxy-3,5,6-trimethylbenzoyl)oxy-2-hydroxy-6-methylbenzoyl]amino]-3-hydroxybutanoic acid
9-O-glucosylmycosporin-2 ring form
C19H29NO11 (447.17405240000005)
(+)-Corynolin-11-O-sulfat|(+)-O-sulfooxy-corynoline|13-methyl-O-sulfooxy-chelidonine|sulfuric acid mono-((5bR)-5b,13-dimethyl-(5br,12bc)-5b,6,7,12b,13,14-hexahydro-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-6t-yl) ester
C21H21NO8S (447.09878260000005)
dichotomide VIII
C20H21N3O9 (447.12777360000007)
A natural product found in Stellaria dichotoma var. lanceolata.
1-(4-Chlorobenzyl)-3-(2-methoxyphenyl)spiro[quinazoline-2(1H),4-piperidine]-4(3H)-one
C26H26ClN3O2 (447.17134460000005)
Asp Gln Ala Asp
C16H25N5O10 (447.16013499999997)
[5-chloro-3-[(1E,3E,5E)-hepta-1,3,5-trienyl]-7-methyl-6,8-dioxo-2H-isoquinolin-7-yl] 3,5-dihydroxyhexanoate
C23H26ClNO6 (447.1448566000001)
Aripiprazole
An N-arylpiperazine that is piperazine substituted by a 4-[(2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)oxy]butyl group at position 1 and by a 2,3-dichlorophenyl group at position 4. It is an antipsychotic drug used for the treatment of Schizophrenia, and other mood disorders. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Aripiprazole (OPC-14597), an atypical antipsychotic, is a potent and high-affinity dopamine D2 receptor partial agonist. Aripiprazole is an inverse agonist at 5-HT2B and 5-HT2A receptors and displays partial agonist actions at 5-HT1A, 5-HT2C, D3, and D4 receptors. Aripiprazole can be used for the research of schizophrenia and COVID19[1][2][3][4].
2-[[4-(2,4-dihydroxy-3,5,6-trimethylbenzoyl)oxy-2-hydroxy-6-methylbenzoyl]amino]-3-hydroxybutanoic acid
Ala Asp Asp Gln
C16H25N5O10 (447.16013499999997)
Ala Asp Glu Asn
C16H25N5O10 (447.16013499999997)
Ala Asp Gly Trp
Ala Asp Asn Glu
C16H25N5O10 (447.16013499999997)
Ala Asp Gln Asp
C16H25N5O10 (447.16013499999997)
Ala Asp Trp Gly
Ala Glu Asp Asn
C16H25N5O10 (447.16013499999997)
Ala Glu Asn Asp
C16H25N5O10 (447.16013499999997)
Ala Gly Asp Trp
Ala Gly Trp Asp
Ala Asn Asp Glu
C16H25N5O10 (447.16013499999997)
Ala Asn Glu Asp
C16H25N5O10 (447.16013499999997)
Ala Gln Asp Asp
C16H25N5O10 (447.16013499999997)
Mefenamic acid Metabolite (b-D-Glucopyranuronic acid, 1-[2-[(3-carboxy-2-methylphenyl)amino]benzoate
Ala Trp Asp Gly
Ala Trp Gly Asp
Cys Asp Asn Pro
Cys Asp Pro Asn
Cys Asn Asp Pro
Cys Asn Pro Asp
Cys Pro Asp Asn
Cys Pro Asn Asp
Cys Pro Gln Thr
C17H29N5O7S (447.17876040000004)
Cys Pro Thr Gln
C17H29N5O7S (447.17876040000004)
Cys Gln Pro Thr
C17H29N5O7S (447.17876040000004)
Cys Gln Thr Pro
C17H29N5O7S (447.17876040000004)
Cys Thr Pro Gln
C17H29N5O7S (447.17876040000004)
Cys Thr Gln Pro
C17H29N5O7S (447.17876040000004)
Asp Ala Asp Gln
C16H25N5O10 (447.16013499999997)
Asp Ala Glu Asn
C16H25N5O10 (447.16013499999997)
Asp Ala Gly Trp
Asp Ala Asn Glu
C16H25N5O10 (447.16013499999997)
Asp Ala Gln Asp
C16H25N5O10 (447.16013499999997)
Asp Ala Trp Gly
Asp Cys Asn Pro
Asp Cys Pro Asn
Asp Asp Ala Gln
C16H25N5O10 (447.16013499999997)
Asp Asp Gln Ala
C16H25N5O10 (447.16013499999997)
Asp Glu Ala Asn
C16H25N5O10 (447.16013499999997)
Asp Glu Gly Gln
C16H25N5O10 (447.16013499999997)
Asp Glu Asn Ala
C16H25N5O10 (447.16013499999997)
Asp Glu Gln Gly
C16H25N5O10 (447.16013499999997)
Asp Gly Ala Trp
Asp Gly Glu Gln
C16H25N5O10 (447.16013499999997)
Asp Gly Gln Glu
C16H25N5O10 (447.16013499999997)
Asp Gly Trp Ala
Asp Asn Ala Glu
C16H25N5O10 (447.16013499999997)
Asp Asn Cys Pro
Asp Asn Glu Ala
C16H25N5O10 (447.16013499999997)
Asp Asn Pro Cys
Asp Pro Cys Asn
Asp Pro Asn Cys
Asp Gln Asp Ala
C16H25N5O10 (447.16013499999997)
Asp Gln Glu Gly
C16H25N5O10 (447.16013499999997)
Asp Gln Gly Glu
C16H25N5O10 (447.16013499999997)
Asp Trp Ala Gly
Asp Trp Gly Ala
Glu Ala Asp Asn
C16H25N5O10 (447.16013499999997)
Glu Ala Asn Asp
C16H25N5O10 (447.16013499999997)
Glu Asp Ala Asn
C16H25N5O10 (447.16013499999997)
Glu Asp Gly Gln
C16H25N5O10 (447.16013499999997)
Glu Asp Asn Ala
C16H25N5O10 (447.16013499999997)
Glu Asp Gln Gly
C16H25N5O10 (447.16013499999997)
Glu Glu Gly Asn
C16H25N5O10 (447.16013499999997)
Glu Glu Asn Gly
C16H25N5O10 (447.16013499999997)
Glu Gly Asp Gln
C16H25N5O10 (447.16013499999997)
Glu Gly Glu Asn
C16H25N5O10 (447.16013499999997)
Glu Gly Gly Trp
Glu Gly Asn Glu
C16H25N5O10 (447.16013499999997)
Glu Gly Gln Asp
C16H25N5O10 (447.16013499999997)
Glu Gly Trp Gly
Glu Asn Ala Asp
C16H25N5O10 (447.16013499999997)
Glu Asn Asp Ala
C16H25N5O10 (447.16013499999997)
Glu Asn Glu Gly
C16H25N5O10 (447.16013499999997)
Glu Asn Gly Glu
C16H25N5O10 (447.16013499999997)
Glu Gln Asp Gly
C16H25N5O10 (447.16013499999997)
Glu Gln Gly Asp
C16H25N5O10 (447.16013499999997)
Glu Trp Gly Gly
Gly Ala Asp Trp
Gly Ala Trp Asp
Gly Asp Ala Trp
Gly Asp Glu Gln
C16H25N5O10 (447.16013499999997)
Gly Asp Gln Glu
C16H25N5O10 (447.16013499999997)
Gly Asp Trp Ala
Gly Glu Asp Gln
C16H25N5O10 (447.16013499999997)
Gly Glu Glu Asn
C16H25N5O10 (447.16013499999997)
Gly Glu Gly Trp
Gly Glu Asn Glu
C16H25N5O10 (447.16013499999997)
Gly Glu Gln Asp
C16H25N5O10 (447.16013499999997)
Gly Glu Trp Gly
Gly Gly Glu Trp
Gly Gly Trp Glu
Gly Asn Glu Glu
C16H25N5O10 (447.16013499999997)
Gly Gln Asp Glu
C16H25N5O10 (447.16013499999997)
Gly Gln Glu Asp
C16H25N5O10 (447.16013499999997)
Gly Trp Ala Asp
Gly Trp Asp Ala
Gly Trp Glu Gly
Gly Trp Gly Glu
Met Asn Pro Ser
C17H29N5O7S (447.17876040000004)
Met Asn Ser Pro
C17H29N5O7S (447.17876040000004)
Met Pro Asn Ser
C17H29N5O7S (447.17876040000004)
Met Pro Ser Asn
C17H29N5O7S (447.17876040000004)
Met Ser Asn Pro
C17H29N5O7S (447.17876040000004)
Met Ser Pro Asn
C17H29N5O7S (447.17876040000004)
Asn Ala Asp Glu
C16H25N5O10 (447.16013499999997)
Asn Ala Glu Asp
C16H25N5O10 (447.16013499999997)
Asn Cys Asp Pro
Asn Cys Pro Asp
Asn Asp Ala Glu
C16H25N5O10 (447.16013499999997)
Asn Asp Cys Pro
Asn Asp Glu Ala
C16H25N5O10 (447.16013499999997)
Asn Asp Pro Cys
Asn Glu Ala Asp
C16H25N5O10 (447.16013499999997)
Asn Glu Asp Ala
C16H25N5O10 (447.16013499999997)
Asn Glu Glu Gly
C16H25N5O10 (447.16013499999997)
Asn Glu Gly Glu
C16H25N5O10 (447.16013499999997)
Asn Gly Glu Glu
C16H25N5O10 (447.16013499999997)
Asn Met Pro Ser
C17H29N5O7S (447.17876040000004)
Asn Met Ser Pro
C17H29N5O7S (447.17876040000004)
Asn Asn Asn Ser
C15H25N7O9 (447.17136800000003)
Asn Asn Ser Asn
C15H25N7O9 (447.17136800000003)
Asn Pro Cys Asp
Asn Pro Asp Cys
Asn Pro Met Ser
C17H29N5O7S (447.17876040000004)
Asn Pro Ser Met
C17H29N5O7S (447.17876040000004)
Asn Ser Met Pro
C17H29N5O7S (447.17876040000004)
Asn Ser Asn Asn
C15H25N7O9 (447.17136800000003)
Asn Ser Pro Met
C17H29N5O7S (447.17876040000004)
Pro Cys Asp Asn
Pro Cys Asn Asp
Pro Cys Gln Thr
C17H29N5O7S (447.17876040000004)
Pro Cys Thr Gln
C17H29N5O7S (447.17876040000004)
Pro Asp Cys Asn
Pro Asp Asn Cys
Pro Met Asn Ser
C17H29N5O7S (447.17876040000004)
Pro Met Ser Asn
C17H29N5O7S (447.17876040000004)
Pro Asn Cys Asp
Pro Asn Asp Cys
Pro Asn Met Ser
C17H29N5O7S (447.17876040000004)
Pro Asn Ser Met
C17H29N5O7S (447.17876040000004)
Pro Gln Cys Thr
C17H29N5O7S (447.17876040000004)
Pro Gln Thr Cys
C17H29N5O7S (447.17876040000004)
Pro Ser Met Asn
C17H29N5O7S (447.17876040000004)
Pro Ser Asn Met
C17H29N5O7S (447.17876040000004)
Pro Thr Cys Gln
C17H29N5O7S (447.17876040000004)
Pro Thr Gln Cys
C17H29N5O7S (447.17876040000004)
Gln Ala Asp Asp
C16H25N5O10 (447.16013499999997)
Gln Cys Pro Thr
C17H29N5O7S (447.17876040000004)
Gln Cys Thr Pro
C17H29N5O7S (447.17876040000004)
Gln Asp Ala Asp
C16H25N5O10 (447.16013499999997)
Gln Asp Asp Ala
C16H25N5O10 (447.16013499999997)
Gln Asp Glu Gly
C16H25N5O10 (447.16013499999997)
Gln Asp Gly Glu
C16H25N5O10 (447.16013499999997)
Gln Glu Asp Gly
C16H25N5O10 (447.16013499999997)
Gln Glu Gly Asp
C16H25N5O10 (447.16013499999997)
Gln Gly Asp Glu
C16H25N5O10 (447.16013499999997)
Gln Gly Glu Asp
C16H25N5O10 (447.16013499999997)
Gln Pro Cys Thr
C17H29N5O7S (447.17876040000004)
Gln Pro Thr Cys
C17H29N5O7S (447.17876040000004)
Gln Thr Cys Pro
C17H29N5O7S (447.17876040000004)
Gln Thr Pro Cys
C17H29N5O7S (447.17876040000004)
Ser Met Asn Pro
C17H29N5O7S (447.17876040000004)
Ser Met Pro Asn
C17H29N5O7S (447.17876040000004)
Ser Asn Met Pro
C17H29N5O7S (447.17876040000004)
Ser Asn Asn Asn
C15H25N7O9 (447.17136800000003)
Ser Asn Pro Met
C17H29N5O7S (447.17876040000004)
Ser Pro Met Asn
C17H29N5O7S (447.17876040000004)
Ser Pro Asn Met
C17H29N5O7S (447.17876040000004)
Thr Cys Pro Gln
C17H29N5O7S (447.17876040000004)
Thr Cys Gln Pro
C17H29N5O7S (447.17876040000004)
Thr Pro Cys Gln
C17H29N5O7S (447.17876040000004)
Thr Pro Gln Cys
C17H29N5O7S (447.17876040000004)
Thr Gln Cys Pro
C17H29N5O7S (447.17876040000004)
Thr Gln Pro Cys
C17H29N5O7S (447.17876040000004)
Trp Ala Asp Gly
Trp Ala Gly Asp
Trp Asp Ala Gly
Trp Asp Gly Ala
Trp Glu Gly Gly
Trp Gly Ala Asp
Trp Gly Asp Ala
Trp Gly Glu Gly
Trp Gly Gly Glu
Pigment A aglycone
6-[ethyl(p-tolyl)amino]-2-methylspiro[isobenzofuran-1(3H),9-[9H]xanthene]-3-one
C30H25NO3 (447.18343400000003)
2-(1-ethylpiperidin-1-ium-1-yl)ethyl 2-hydroxy-2,2-diphenylacetate,bromide
1-(Triphenylmethyl)-L-histidine methyl ester monohydrochloride
C26H26ClN3O2 (447.17134460000005)
Ethyl (E)-7-[4-(4-fluorophenyl)-2-(cyclopropyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoate
C27H26FNO4 (447.18457680000006)
Diphenhydramine citrate
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D018926 - Anti-Allergic Agents
4-Nitrophenyl 2-O-(α-L-Fucopyranosyl)-α-D-galactopyranoside
Fmoc-(R)-3-Amino-3-(2,3-Dimethoxy-Phenyl)-Propionic Acid
Elvitegravir
C23H23ClFNO5 (447.12487100000004)
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AJ - Integrase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D019429 - Integrase Inhibitors
2-Nitrophenyl2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-a-D-glucopyranoside
N-(5-TERT-BUTYL-ISOXAZOL-3-YL)-N-[4-(7-IMIDAZO[2,1-B][1,3]BENZOTHIAZOL-2-YL)PHENYL]UREA
C23H21N5O3S (447.1365036000001)
4SC-202
C23H21N5O3S (447.1365036000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
Gimatecan
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
2-(4-AMINO-2-BUTOXYPYRIDIN-3-YL)-4-BROMO-N,N-DIISOPROPYLBENZAMIDE
1H-Benzimidazole,5,6-dimethyl-1-[[4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl]sulfonyl]-(9CI)
propantheline bromide
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Propantheline bromide is an orally active mAChR antagonist. Propantheline bromide can be used in the research of smooth muscle dysfunction, excessive sweating, cramps or spasms of the stomach, intestines or bladder, and involuntary urination[1][2][3].
Phenyltoloxamine citrate
C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
p-Nitrophenyl 2-O-(b-L-Fucopyranosyl)-b-D-galactopyranoside
3-METHOXY-N-(2-(3-(PIPERAZIN-1-YLMETHYL)IMIDAZO[2,1-B]THIAZOL-6-YL)PHENYL)BENZAMIDE
N-(6-Amino-5-chloro-3-pyridinyl)-5-{[3-(2-cyano-2-propanyl)benzoy l]amino}-2-methylbenzamide
JTC-801
C26H26ClN3O2 (447.17134460000005)
JTC-801 is a selective opioid receptor-like1 (ORL1) receptor antagonist, binding to ORL1 receptor with a Ki value of 8.2?nM.
dodeclonium bromide
C22H39BrClNO (447.19033740000003)
C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent
(S)-N-(2,4-difluorobenzyl)-2-ethyl-9-hydroxy-1,8-dioxo-1,2,2,4,4,5,6,8-octahydrospiro[pyran-3,3-pyrido[1,2-a]pyrazine]-7-carboxamide
Ninhydrine, ozone friendly ready to use spray for TLC chromatography
(2R)-4-benzyl-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]morpholin-3-one
C21H19F6NO3 (447.1269056000001)
Decoglurant
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent Decoglurant (RO4995819) is a negative allosteric modulator of mGluR2 and mGluR3. Decoglurant is developed as an antidepressant[1].
Cetocycline hydrochloride
C22H22ClNO7 (447.10847320000005)
C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
9-(1-Methyl-4-pyrazolyl)-1-[1-(1-oxoprop-2-enyl)-2,3-dihydroindol-6-yl]-2-benzo[h][1,6]naphthyridinone
(Z)-3-(5-(4-ethylbenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)-N-(3-morpholinopropyl)propanamide
C22H29N3O3S2 (447.16502440000005)
3-[N-(2-Carboxyethyl)methylamino]-7-[N-ethyl(3-sulfonatopropyl)amino]phenoxazin-5-ium
C21H25N3O6S (447.14639900000003)
5-[2-(4-methoxyphenyl)ethynyl]-1-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-2,3-dihydropyridin-6-one
[4-({6-[Allyl(methyl)amino]hexyl}oxy)-2-fluorophenyl](4-bromophenyl)methanone
5-O-(N-(L-Threonyl)-sulfamoyl)adenosine
C14H21N7O8S (447.11722660000004)
N-[(Furan-2-YL)carbonyl]-(S)-leucyl-(R)-[1-amino-2(1H-indol-3-YL)ethyl]-phosphonic acid
C21H26N3O6P (447.1559146000001)
(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]pyrimidin-2-YL}amino)phenoxy]-3-(dimethylamino)propan-2-OL
N-(5-{[(2s)-4-Amino-2-(3-Chlorophenyl)butanoyl]amino}-1h-Indazol-3-Yl)benzamide
1-Menaphthyl Glutathione Conjugate
C21H25N3O6S (447.14639900000003)
(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]pyrimidin-2-YL}amino)phenoxy]-3-(dimethylamino)propan-2-OL
Amuvatinib
C23H21N5O3S (447.1365036000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
Pipamperone dihydrochloride
C21H32Cl2FN3O2 (447.18554839999996)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
Methyl (2S)-2-[[4-[[(2R)-2-amino-3-sulfanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulfanylbutanoate
C22H29N3O3S2 (447.16502440000005)
(2E,6E,10E)-3,7,11,15-Tetramethylhexadeca-2,6,10,14-tetraen-1-yl diphosphate
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
kaempferol 3-O-beta-D-galactoside(1-)
C21H19O11- (447.09273240000005)
An organic anion obtained by selective deprotonation of the 7-hydroxy group of kaempferol 3-O-beta-D-galactoside; major species at pH 7.3.
Quercitrin-7-olate
C21H19O11- (447.09273240000005)
Conjugate base of quercitrin arising from selective deprotonation of the 7-hydroxy group; major species at pH 7.3.
5alpha,9alpha,10beta-Labda-8(20),13-dien-15-yl diphosphate(3-)
cyanidin 3-O-beta-D-glucoside(1-)
C21H19O11- (447.09273240000005)
An organic anion obtained by deprotonation of the 5 and 7 positions of cyanidin 3-O-beta-D-glucoside. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
3-methyl-5-[(1R,4aR,8aR)-5,5,8a-trimethyl-2-methylidenedecahydronaphthalen-1-yl]pent-2-en-1-yl diphosphate
kaempferol 3-O-beta-D-glucoside(1-)
C21H19O11- (447.09273240000005)
5alpha,9beta,10alpha-Labda-8(20),13-dien-15-yl diphosphate(3-)
2-(4-Hydroxy-3-oxylatophenyl)-8-(beta-D-glucopyranosyl)-5,7-dihydroxy-4H-1-benzopyran-4-one
C21H19O11- (447.09273240000005)
4-[5,7-dihydroxy-4-oxo-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-2-yl]-2-hydroxyphenolate
C21H19O11- (447.09273240000005)
D-glucuronosyl-2-methyl-4-(3-methyl-1,4-dioxonaphthalen-2-yl)butanoate
19-ethyl-19-hydroxy-5-[(E)-(2-methylpropan-2-yl)oxyiminomethyl]-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
19-ethyl-19-hydroxy-10-[(E)-(2-methylpropan-2-yl)oxyiminomethyl]-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
(3E,7aS,12aR)-3-(1H-imidazol-4-ylmethylidene)-6,12-dimethoxy-7a-(2-methylbut-3-en-2-yl)-7a,12-dihydro-1H,5H-imidazo[1,2:1,2]pyrido[2,3-b]indole-2,5(3H)-dione
ethyl 5-[(thien-2-ylacetyl)amino]-1-{2-[(thien-2-ylacetyl)oxy]ethyl}-1H-pyrazole-4-carboxylate
C20H21N3O5S2 (447.09225760000004)
2-[4-(3,4-dimethoxyphenyl)-1H-pyrazol-3-yl]-5-[(4-nitrobenzyl)oxy]phenol
C24H21N3O6 (447.14302860000004)
(3R)-7-phenyl-2-(phenylmethyl)-3-[4-(trifluoromethyl)phenyl]-3a,6,7,7a-tetrahydro-3H-isoindol-1-one
luteolin 7-O-beta-D-glucoside(1-)
C21H19O11- (447.09273240000005)
A flavonoid oxoanion obtained by deprotonation of the 5-hydroxy group of luteolin 7-O-beta-D-glucoside. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
cyanidin 3-O-beta-D-galactoside(1-)
C21H19O11- (447.09273240000005)
A phenolate anion obtained by deprotonation of the 5- and 7-hydroxy groups of cyanidin 3-O-beta-D-galactoside. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
4-[[4-(3-Methylanilino)-3,5-dinitrophenyl]-oxomethyl]-1,3-dihydroquinoxalin-2-one
2-[[(2-Methoxy-4-nitroanilino)-sulfanylidenemethyl]amino]benzene-1,4-dicarboxylic acid diethyl ester
C20H21N3O7S (447.11001560000005)
1-[(7,8-dimethyl-2-oxo-1H-quinolin-3-yl)methyl]-1-(2-furanylmethyl)-3-(2-methoxyphenyl)thiourea
3-(Methanesulfonamido)benzoic acid [1-[4-(4-morpholinyl)anilino]-1-oxopropan-2-yl] ester
C21H25N3O6S (447.14639900000003)
N-[2-[[2-(cyclohexylamino)-2-oxo-1-thiophen-2-ylethyl]-(2-methoxyethyl)amino]-2-oxoethyl]-2-furancarboxamide
C22H29N3O5S (447.18278240000006)
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide
C21H25N3O6S (447.14639900000003)
(3R)-3-{[(3R)-3-{[(3R)-3-{[(3R)-3-{[(3R)-3-hydroxybutanoyl]oxy}butanoyl]oxy}butanoyl]oxy}butanoyl]oxy}butanoate
C20H31O11- (447.18662759999995)
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-2-ylmethyl)acetamide
C21H25N3O6S (447.14639900000003)
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-2-ylmethyl)acetamide
C21H25N3O6S (447.14639900000003)
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-2-ylmethyl)acetamide
C21H25N3O6S (447.14639900000003)
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-2-ylmethyl)acetamide
C21H25N3O6S (447.14639900000003)
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide
C21H25N3O6S (447.14639900000003)
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide
C21H25N3O6S (447.14639900000003)
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
C21H25N3O6S (447.14639900000003)
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
C21H25N3O6S (447.14639900000003)
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
C21H25N3O6S (447.14639900000003)
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
C21H25N3O6S (447.14639900000003)
(1S,2aS,8bS)-4-benzoyl-N-(2-chlorophenyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide
(1R,2aR,8bR)-4-benzoyl-N-(2-chlorophenyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide
[(1R)-7-methoxy-2,9-dimethyl-1-thiophen-2-ylsulfonyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
[5-Chloro-3-[(1E,3E,5E)-hepta-1,3,5-trienyl]-6-hydroxy-7-methyl-8-oxoisoquinolin-7-yl] 3,5-dihydroxyhexanoate
C23H26ClNO6 (447.1448566000001)
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide
C21H25N3O6S (447.14639900000003)
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide
C21H25N3O6S (447.14639900000003)
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
C21H25N3O6S (447.14639900000003)
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
C21H25N3O6S (447.14639900000003)
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
C21H25N3O6S (447.14639900000003)
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide
C21H25N3O6S (447.14639900000003)
(1S,2aR,8bR)-4-benzoyl-N-(2-chlorophenyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide
(1R,2aS,8bS)-4-benzoyl-N-(2-chlorophenyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide
[(1S)-7-methoxy-2,9-dimethyl-1-thiophen-2-ylsulfonyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
2-thio-N(6)-dimethylallyladenine 5-monophosphate
C15H22N5O7PS (447.09775120000006)
6-O-[5-hydroxy-3-(2-hydroxyphenyl)-4-oxo-4H-chromen-6-yl]-L-gulonate
C21H19O11- (447.09273240000005)
N-[3-(4-tert-butyl-1-pyridin-1-iumyl)-1,4-dioxo-2-naphthalenyl]benzenesulfonamide
C25H23N2O4S+ (447.13784580000004)
2-methoxyethyl (2S)-2-(4-tert-butylphenyl)-2-cyano-3-oxo-3-[2-(trifluoromethyl)phenyl]propanoate
C24H24F3NO4 (447.16573400000004)
2-methoxyethyl (2R)-2-(4-tert-butylphenyl)-2-cyano-3-oxo-3-[2-(trifluoromethyl)phenyl]propanoate
C24H24F3NO4 (447.16573400000004)
Methyl 4-[1-(furan-2-ylmethyl)-3-(4-methoxybenzoyl)-4,5-dioxopyrrolidin-2-yl]benzoate
C25H21NO7 (447.13179560000003)
4-[(2,2-Dioxo-2lambda6-thia-3-azatricyclo[6.3.1.04,12]dodeca-1(11),4,6,8(12),9-pentaen-3-yl)methyl]-N-[(E)-(3-oxocyclohexylidene)amino]benzamide
C24H21N3O4S (447.1252706000001)
2-[[4-(3-Ethoxy-1,1,1-trifluoro-2-hydroxy-3-oxopropan-2-yl)-2-methylphenyl]iminomethyl]propanedioic acid diethyl ester
ethyl 2-[3-(1H-benzimidazol-2-yl)-3-cyano-2-oxopropyl]sulfanyl-1-ethylbenzimidazole-5-carboxylate
C23H21N5O3S (447.1365036000001)
1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(Z)-1-(2-hydroxyphenyl)ethylideneamino]-5-[(N-methylanilino)methyl]triazole-4-carboxamide
C21H21N9O3 (447.17672760000005)
5-Hydroxy-2-(4-hydroxyphenyl)-4-oxo-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-3-olate
C21H19O11- (447.09273240000005)
(-)-kolavenyl diphosphate(3-)
An organophosphate oxoanion obtained by deprotonation of diphosphate OH groups of (-)-kolavenyl diphosphate; major species at pH 7.3.
2-trans,6-trans,10-trans-geranylgeranyl diphosphate(3-)
Trianion of 2-trans,6-trans,10-trans-geranylgeranyl diphosphate.
2-cis,6-trans,10-trans-geranylgeranyl diphosphate(3-)
The organophosphate oxoanion formed by global deprotonation of the diphosphate group in 2-cis,6-trans,10-trans-geranylgeranyl diphosphate; principal microspecies at pH 7.3.
Glucosylceramide synthase-IN-2
C22H20F3N3O4 (447.14058360000007)
Glucosylceramide synthase-IN-2 (compound T-690) is a potent, brain-penetrant and orally active glucosylceramide synthase (GCS) inhibitor with IC50s of 15 nM and 190 nM for human GCS and mouse GCS, respectively.Glucosylceramide synthase-IN-2 exhibits noncompetitive type inhibition with C8-ceramide and UDP-glucose.Glucosylceramide synthase-IN-2 can be used for Gaucher's disease research[1].
VU533
C21H22FN3O3S2 (447.10865540000003)
APE-PLD (VU533) activator is a potent NAPE-PLD activator with an EC50 value of 0.30 μM. NAPE-PLD activator (VU533) can enhance NAPE-PLD activity and increase efferocytosis by macrophages. NAPE-PLD activator (VU533) can be used for cardiometabolic diseases research[1].
VU534
C21H22FN3O3S2 (447.10865540000003)
VU534 is a NAPE-PLD activator, with an EC50 of 0.30 μM. VU534 is dual inhibitors of FAAH and sEH (IC50 of 1.2 μM). VU534 increases efferocytosis in a NAPE-PLD dependent manner. VU534 has the potential for cardiometabolic diseases study [1] .
methyl (2e,3e,5e,7e,9e)-11-[(1s,5s)-2,4-dihydroxy-4-(2-hydroxyethyl)-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl]-2-(2-hydroxyethylidene)-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoate
1-acetyl-4-hydroxy-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-9h-pyrido[3,4-b]indole-3-carboximidic acid
C20H21N3O9 (447.12777360000007)
[(1r,12s,13r)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-yl]oxidanesulfonic acid
C21H21NO8S (447.09878260000005)
2-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-n-(3-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}propyl)-3-hydroxybutanimidic acid
5-({4,5-bis[(4-methoxyphenyl)methyl]-1-methylimidazol-2-yl}imino)-2-hydroxy-3-methylimidazol-4-one
(2s,3r,4s,5s,6r)-2-{[(9bs,11r)-8-hydroxy-11-methoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2-({8-hydroxy-11-methoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
methyl (2e,3e,5e,7e,9e)-11-[(1s,4s,5r)-2,4-dihydroxy-4-(2-hydroxyethyl)-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl]-2-(2-hydroxyethylidene)-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoate
(5r)-1-[(5s)-5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]-5-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)pyrrolidin-2-one
C19H29NO11 (447.17405240000005)
(1r,21s,22s,23r)-4-chloro-22-hydroxy-11,21,23-trimethyl-24-oxa-20-azahexacyclo[19.3.1.0²,¹⁹.0⁵,¹⁸.0⁷,¹⁶.0⁸,¹³]pentacosa-2,4,7,9,11,13,15,18-octaene-6,17-dione
C26H22ClNO4 (447.1237282000001)
[(2r,3s,4s,5r,6r)-6-[(s)-cyano(phenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate
(2r,3r,4s,5s,6r)-2-{[(9bs,11r)-7-hydroxy-8-methoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-11-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
5-({5-[(4-hydroxyphenyl)methyl]-4-[(4-methoxyphenyl)methyl]-1-methylimidazol-2-yl}imino)-1,3-dimethylimidazolidine-2,4-dione
(2s,3r,4s,5s,6r)-2-{[(9bs,11r)-7-hydroxy-11-methoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-8-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r)-2-amino-3-(2,3-dihydroxybenzoyloxy)-n-(3-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}propyl)butanimidic acid
{6-[cyano(phenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl}methyl 3,4,5-trihydroxybenzoate
(2s,3r,4s,5s,6r)-2-{[(1r)-6-hydroxy-1-[(4-hydroxyphenyl)methyl]-2-methyl-3,4-dihydro-1h-isoquinolin-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
3-amino-5-hydroxy-4-{6-methyl-6',7,8,8'-tetrahydro-2h,2'h-spiro[[1,3]dioxolo[4,5-g]isoquinoline-5,7'-indeno[4,5-d][1,3]dioxol]-8'-yl}pyrrol-2-one
C24H21N3O6 (447.14302860000004)
(9s,14e)-15-hydroxy-14-(3h-imidazol-4-ylmethylidene)-2,11-dimethoxy-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.0¹,¹³.0³,⁸]hexadeca-3,5,7,10,15-pentaen-12-one
14-(1h-imidazol-4-ylmethylidene)-2,11-dimethoxy-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.0¹,¹³.0³,⁸]hexadeca-3,5,7,10-tetraene-12,15-dione
1-acetyl-4-hydroxy-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-9h-pyrido[3,4-b]indole-3-carboximidic acid
C20H21N3O9 (447.12777360000007)
1-[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)pyrrolidin-2-one
C19H29NO11 (447.17405240000005)
2-({7-hydroxy-11-methoxy-2h,4h,5h,10h,11h-indolo[7a,1-a]isoquinolin-8-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
methyl 3,4,5-trimethoxy-2-[4-oxo-2-(pyridin-3-yl)quinazolin-3-yl]benzoate
C24H21N3O6 (447.14302860000004)
n-[2-hydroxy-5-({8-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)-7-oxophenoxazin-3-yl}methyl)phenyl]ethanimidic acid
C24H21N3O6 (447.14302860000004)
3-amino-5-hydroxy-4-[(5r,8'r)-6-methyl-6',7,8,8'-tetrahydro-2h,2'h-spiro[[1,3]dioxolo[4,5-g]isoquinoline-5,7'-indeno[4,5-d][1,3]dioxol]-8'-yl]pyrrol-2-one
C24H21N3O6 (447.14302860000004)
(2s,3s)-2-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-n-(3-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}propyl)-3-hydroxybutanimidic acid
2-({6-hydroxy-1-[(4-hydroxyphenyl)methyl]-2-methyl-3,4-dihydro-1h-isoquinolin-7-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
{13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-yl}oxidanesulfonic acid
C21H21NO8S (447.09878260000005)
4-chloro-22-hydroxy-11,21,23-trimethyl-24-oxa-20-azahexacyclo[19.3.1.0²,¹⁹.0⁵,¹⁸.0⁷,¹⁶.0⁸,¹³]pentacosa-2,4,7,9,11,13,15,18-octaene-6,17-dione
C26H22ClNO4 (447.1237282000001)
2-amino-3-(2,3-dihydroxybenzoyloxy)-n-(3-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}propyl)butanimidic acid
(5z)-5-({5-[(4-hydroxyphenyl)methyl]-4-[(4-methoxyphenyl)methyl]-1-methylimidazol-2-yl}imino)-1,3-dimethylimidazolidine-2,4-dione
(2s,3r,4s,5s,6r)-2-{[(2s,3s,4r,5r)-5-(6-aminopurin-9-yl)-2-fluoro-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
C16H22FN5O9 (447.14014940000004)
(1r,9s,14e)-15-hydroxy-14-(3h-imidazol-4-ylmethylidene)-2,11-dimethoxy-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.0¹,¹³.0³,⁸]hexadeca-3,5,7,10,15-pentaen-12-one
3-amino-5-hydroxy-4-[(5r,8's)-6-methyl-6',7,8,8'-tetrahydro-2h,2'h-spiro[[1,3]dioxolo[4,5-g]isoquinoline-5,7'-indeno[4,5-d][1,3]dioxol]-8'-yl]pyrrol-2-one
C24H21N3O6 (447.14302860000004)